President Roh to emphasize on R&D investment for bio-engineering.

Published: 2004-10-28 06:58:00

Updated: 2004-10-28 06:58:00

President Roh Moo-hyun announced through the government national policy statement delivered in the National Assembly by Prime Minister on Oct. 25 that the R&D investment for the bio-engineering should be expanded while the drug safety control strictly intensified.

The statement stressed on whi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK